Sentence examples for evidence for baseline from inspiring English sources

These were: 1. Flawed Trial Design: Patients not stratified properly and the evidence for baseline shifts in the studied population.

In summary, this large study supports evidence for baseline age, WHR, pulse pressure, and non-HDL cholesterol being important risk factors for all-cause as well as non-CVD mortality in patients with type 1 diabetes.

The present study investigates correlates of adherence to yoga and exercise interventions in a population of healthy seniors, contributing evidence for baseline measures including mood, physical functioning, general health, and fatigue impacting adherence rates and probability of study completion.

Instead, the Cochrane authors completely dismiss the baseline register data in Miguel and Kremer (2004) as unreliable evidence for baseline balance, while including the Watkins (1996) data in their meta-analysis of school participation impacts, giving it equal weight with the Miguel and Kremer (2004) school participation impact evidence (which uses more rigorous outcome data).

When a recommendation varies in relationship to baseline risk, the evidence for determining baseline risk should be assessed appropriately and explicitly.

Trials related to the topics of GIC-based fissure sealants and GIC (including ART) comparison to amalgam restorations included limited evidence for equivocal baseline characteristics between intervention groups.

We also found no evidence for increased baseline or intra-treatment OPN values in patients that had increased acute toxicity (i.e., maximum CTCAE scores 2 out of 3 vs 0 out of 1) during EBRT (see Supplementary Table 4).

We found no effect of relaxation in the rate of societal learning, although there was strong evidence for both a baseline removal rate and an effect of learning (Table 2).

The main sources of the evidence for both the baseline and evaluation phases were the IDIs.

Although we provide strong evidence for this elevated baseline risk in the rheumatology patient population, identifying high-risk patients within each disease and reducing the risk by treatment of disease activity or antiplatelet prophylaxis cannot be determined on the basis of our meta-analysis.

First, there is evidence for an increasing baseline resistance to N t RTIs and NNRTIs among treatment-naive patients, which may compromise the efficacy of these treatments [2], particularly in sub-Saharan Africa where the estimated prevalence of primary NNRTI resistance reached 3.4% in 2009 [3].